Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

261 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapeutic Strategies for Targeting CDKN2A Loss in Melanoma.
Kreuger IZM, Slieker RC, van Groningen T, van Doorn R. Kreuger IZM, et al. Among authors: van doorn r, van groningen t. J Invest Dermatol. 2023 Jan;143(1):18-25.e1. doi: 10.1016/j.jid.2022.07.016. Epub 2022 Sep 16. J Invest Dermatol. 2023. PMID: 36123181 Free article. Review.
Cutaneous anaplastic large cell lymphoma and peripheral T-cell lymphoma NOS show distinct chromosomal alterations and differential expression of chemokine receptors and apoptosis regulators.
van Kester MS, Tensen CP, Vermeer MH, Dijkman R, Mulder AA, Szuhai K, Willemze R, van Doorn R. van Kester MS, et al. Among authors: van doorn r. J Invest Dermatol. 2010 Feb;130(2):563-75. doi: 10.1038/jid.2009.270. Epub 2009 Aug 27. J Invest Dermatol. 2010. PMID: 19710685 Free article.
Somatic BRAF and NRAS mutations in familial melanomas with known germline CDKN2A status: a GenoMEL study.
Zebary A, Omholt K, van Doorn R, Ghiorzo P, Harbst K, Hertzman Johansson C, Höiom V, Jönsson G, Pjanova D, Puig S, Scarra GB, Harland M, Olsson H, Egyhazi Brage S, Palmer J, Kanter-Lewensohn L, Vassilaki I, Hayward NK, Newton-Bishop J, Gruis NA, Hansson J; Melanoma Genetics Consortium (GenoMEL). Zebary A, et al. Among authors: van doorn r. J Invest Dermatol. 2014 Jan;134(1):287-290. doi: 10.1038/jid.2013.270. Epub 2013 Jun 14. J Invest Dermatol. 2014. PMID: 23771122 Free article. No abstract available.
Promoter CpG island hypermethylation in dysplastic nevus and melanoma: CLDN11 as an epigenetic biomarker for malignancy.
Gao L, van den Hurk K, Moerkerk PTM, Goeman JJ, Beck S, Gruis NA, van den Oord JJ, Winnepenninckx VJ, van Engeland M, van Doorn R. Gao L, et al. Among authors: van den oord jj, van den hurk k, van doorn r, van engeland m. J Invest Dermatol. 2014 Dec;134(12):2957-2966. doi: 10.1038/jid.2014.270. Epub 2014 Jul 7. J Invest Dermatol. 2014. PMID: 24999589 Free article.
Prognostic Significance of Promoter Hypermethylation and Diminished Gene Expression of SYNPO2 in Melanoma.
Gao L, van den Hurk K, Nsengimana J, Laye JP, van den Oord JJ, Beck S, Gruis NA, Zoutman WH, van Engeland M, Newton-Bishop JA, Winnepenninckx VJ, van Doorn R. Gao L, et al. Among authors: van den oord jj, van den hurk k, van doorn r, van engeland m. J Invest Dermatol. 2015 Sep;135(9):2328-2331. doi: 10.1038/jid.2015.163. Epub 2015 Apr 28. J Invest Dermatol. 2015. PMID: 25918983 Free article. No abstract available.
261 results